Mega Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Public pharmaceutical manufacturer · Lahore · Pakistan
Lahore pharmaceutical manufacturer producing general and cephalosporin medicines and marketing a broad branded-generic portfolio.
Mega Pharmaceuticals products in Pakistan
Mega Pharmaceuticals limited has 127 medicine presentations registered in Pakistan under 47 brands, covering 40 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and CNS & mental health. Its brands with the most registered strengths and packs are ATL (Atenolol), Megafast (Fexofenadine), Megapol (Paracetamol) and Megazole (Omeprazole). 127 products have an official DRAP price on MedInfoBase. See all 47 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Public pharmaceutical manufacturer
- Website
- megapharma.com.pk ↗
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 63%
Company location
No exact premises location is published without a defensible source.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Mega Pharmaceuticals limited is priced against the market
116 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| AgoutSource observed | Allopurinol | 300 mg | Tablet | 2x10's | 057542Official source ↗ | No indexed price | — | — |
| ATL | Atenolol | 50 mg | Tablet | 2x10's | 037842 | PKR 143.54 | PKR 7.18/tablet | 🔒 Pharma Pro |
| ATL | Atenolol | 50 mg | Tablet | 1 x 20’s | 037842 | PKR 143.54 | PKR 7.18/tablet | 🔒 Pharma Pro |
| ATL | Atenolol | 50 mg | Tablet | 25 x 20's | 037842 | PKR 3,030.77 | PKR 6.06/tablet | 🔒 Pharma Pro |
| ATL | Atenolol | 100 mg | Tablet | 2x10's | 037843 | PKR 205.06 | PKR 10.25/tablet | 🔒 Pharma Pro |
| ATL | Atenolol | 100 mg | Tablet | 25 x 10's | 037843 | PKR 2,164.95 | PKR 8.66/tablet | 🔒 Pharma Pro |
| ATL | Atenolol | 100 mg | Tablet | 25 x 20's | 037843 | PKR 4,329.90 | PKR 8.66/tablet | 🔒 Pharma Pro |
| Bisomeg | Bisoprolol fumarate | 2.5 mg | Tablet | 14's | 110647 | PKR 44.30 | PKR 3.16/tablet | 🔒 Pharma Pro |
| Bisomeg | Bisoprolol fumarate | 5 mg | Tablet | 20's | 110648 | PKR 165.03 | PKR 8.25/tablet | 🔒 Pharma Pro |
| Bisomeg | Bisoprolol fumarate | 10 mg | Tablet | 20's | 110649 | PKR 297.06 | PKR 14.85/tablet | 🔒 Pharma Pro |
| Bravofen | Ibuprofen | 200 mg | Tablet | 10 x10’s | 042880 | PKR 249.58 | PKR 2.50/tablet | 🔒 Pharma Pro |
| Bravofen | Ibuprofen | 200 mg | Tablet | 10 x 50's | 042880 | PKR 1,073.19 | PKR 2.15/tablet | 🔒 Pharma Pro |
| Bravofen | Ibuprofen | 400 mg | Tablet | 25 x10’s | 042881 | PKR 913.13 | PKR 3.65/tablet | 🔒 Pharma Pro |
| C-Span | Cefixime | 100 mg/5 mL | Suspension | 60 mL | 032874 | PKR 418.89 | PKR 6.98/mL | 🔒 Pharma Pro |
| C-Span | Cefixime | 100 mg/5 mL | Suspension | 30 mL | 032874 | PKR 299.20 | PKR 9.97/mL | 🔒 Pharma Pro |
| C-Span | Cefixime | 400 mg | Capsule | 1x5's | 034336 | PKR 563.10 | PKR 112.62/capsule | 🔒 Pharma Pro |
| C-Span | Cefixime | 400 mg | Capsule | 10x5's | 034336 | PKR 5,964.14 | PKR 119.28/capsule | 🔒 Pharma Pro |
| C-Span DS | Cefixime | 200 mg/5 mL | Suspension | 30 mL | 068056 | PKR 404.32 | PKR 13.48/mL | 🔒 Pharma Pro |
| Cardiovastin | Simvastatin | 10 mg | Tablet | 1 x 20’s | 032862 | PKR 628.33 | PKR 31.42/tablet | 🔒 Pharma Pro |
| Cardiovastin | Simvastatin | 10 mg | Tablet | 1 x 10's | 032862 | PKR 331.12 | PKR 33.11/tablet | 🔒 Pharma Pro |
| Cardiovastin | Simvastatin | 20 mg | Tablet | 1 x 20’s | 034335 | PKR 947.48 | PKR 47.37/tablet | 🔒 Pharma Pro |
| Cardiovastin | Simvastatin | 20 mg | Tablet | 1 x 10's | 034335 | PKR 498.67 | PKR 49.87/tablet | 🔒 Pharma Pro |
| Celoxime Dry Powder | Cefuroxime | 750 mg | Dry powder for injection | Vial | 047108 | PKR 236.88 | PKR 236.88/vial/unit | 🔒 Pharma Pro |
| CTZ Dry Powder | Ceftriaxone | 250 mg | Dry powder for injection | Vial | 047102 | PKR 201.46 | PKR 201.46/vial/unit | 🔒 Pharma Pro |
| CTZ Dry Powder | Ceftriaxone | 500 mg | Dry powder for injection | Vial | 047103 | PKR 339.10 | PKR 339.10/vial/unit | 🔒 Pharma Pro |
| CTZ Dry Powder | Ceftriaxone | 1 g | Dry powder for injection | Vial | 047104 | PKR 640.30 | PKR 640.30/vial/unit | 🔒 Pharma Pro |
| Daisy | Cetirizine | 10 mg | Tablet | 25 x 20's | 032865 | PKR 4,319.44 | PKR 8.64/tablet | 🔒 Pharma Pro |
| Daisy | Cetirizine | 10 mg | Tablet | 1 x 10's | 032865 | PKR 104.85 | PKR 10.49/tablet | 🔒 Pharma Pro |
| Daisy | Cetirizine | 10 mg | Tablet | 1 x 20's | 032865 | PKR 176.37 | PKR 8.82/tablet | 🔒 Pharma Pro |
| Daisy | Cetirizine | 10 mg | Tablet | 2 x 15's | 032865 | PKR 259.17 | PKR 8.64/tablet | 🔒 Pharma Pro |
| Dawn | Risperidone | 2 mg | Tablet | 25 x 20's | 037844 | PKR 9,687.06 | PKR 19.37/tablet | 🔒 Pharma Pro |
| Dawn | Risperidone | 2 mg | Tablet | 1 x 10's | 037844 | PKR 229.39 | PKR 22.94/tablet | 🔒 Pharma Pro |
| Dawn | Risperidone | 4 mg | Tablet | 10's | 111987 | PKR 514.90 | PKR 51.49/tablet | 🔒 Pharma Pro |
| Delexin | Cephalexin | 125 mg/5 mL | Suspension | 60 mL | 048319 | PKR 117.69 | PKR 1.96/mL | 🔒 Pharma Pro |
| Delexin | Cephalexin | 250 mg/5 mL | Suspension | 60 mL | 048320 | PKR 203.46 | PKR 3.39/mL | 🔒 Pharma Pro |
| Delexin | Cephalexin | 250 mg | Capsule | 12's | 049078 | PKR 203.46 | PKR 16.96/capsule | 🔒 Pharma Pro |
| Delexin | Cephalexin | 500 mg | Capsule | 12's | 049079 | PKR 411.96 | PKR 34.33/capsule | 🔒 Pharma Pro |
| Deprezac | Fluoxetine | 20 mg | Capsule | 10's | 078946 | PKR 129.66 | PKR 12.97/capsule | 🔒 Pharma Pro |
| DX-Lanso 30mg CapsuleRegistry verified | Dexlansoprazole | — | — | — | 127378Official source ↗ | No indexed price | — | — |
| DX-Lanso 60mg CapsuleRegistry verified | Dexlansoprazole | — | — | — | 127379Official source ↗ | No indexed price | — | — |
| Ecogyl | Metronidazole | 400 mg | Tablet | 20's | 080890 | PKR 72.45 | PKR 3.62/tablet | 🔒 Pharma Pro |
| Glide | Gliclazide | 80 mg | Tablet | 2 x 10's | 032858 | PKR 208.75 | PKR 10.44/tablet | 🔒 Pharma Pro |
| Glimetica | Glibenclamide + Metformin | 250 mg + 1.25 mg | Tablet | 3x10's | 057539 | PKR 111.09 | PKR 3.70/tablet | No comparator |
| Glimetica | Glibenclamide + Metformin | 500 mg + 2.50 mg | Tablet | 2x10's | 057540 | PKR 137.63 | PKR 6.88/tablet | No comparator |
| Glucoban | Glibenclamide | 5 mg | Tablet | 6 x 10's | 032859 | PKR 172.21 | PKR 2.87/tablet | 🔒 Pharma Pro |
| Glucoban | Glibenclamide | 5 mg | Tablet | 25 x 20’s | 032859 | PKR 1,150.02 | PKR 2.30/tablet | 🔒 Pharma Pro |
| Glucoban | Glibenclamide | 5 mg | Tablet | 5 x 20’s | 032859 | PKR 239.58 | PKR 2.40/tablet | 🔒 Pharma Pro |
| Leocin | Levofloxacin | 250 mg | Tablet | 10 x 10's | 032888 | PKR 3,303.22 | PKR 33.03/tablet | 🔒 Pharma Pro |
| Leocin | Levofloxacin | 250 mg | Tablet | 1 x 10's | 032888 | PKR 359.05 | PKR 35.91/tablet | 🔒 Pharma Pro |
| Leocin | Levofloxacin | 500 mg | Tablet | 5 x 10's | 032889 | PKR 2,652.95 | PKR 53.06/tablet | 🔒 Pharma Pro |
All 47 Mega Pharmaceuticals brands in Pakistan
- ATL Atenolol · 100 mg tablet, 50 mg tablet
- Bisomeg Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
- Bravofen Ibuprofen · 200 mg tablet, 400 mg tablet
- C-Span Cefixime · 100 mg/5 mL suspension, 400 mg capsule
- C-Span DS Cefixime · 200 mg/5 mL suspension
- Cardiovastin Simvastatin · 10 mg tablet, 20 mg tablet
- Celoxime Dry Powder Cefuroxime · 750 mg injection
- CTZ Dry Powder Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Daisy Cetirizine · 10 mg tablet
- Dawn Risperidone · 2 mg tablet, 4 mg tablet
- Delexin Cephalexin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
- Deprezac Fluoxetine · 20 mg capsule
- Ecogyl Metronidazole · 400 mg tablet
- Glide Gliclazide · 80 mg tablet
- Glimetica Glibenclamide + Metformin · 250 mg + 1.25 mg tablet, 500 mg + 2.50 mg tablet
- Glucoban Glibenclamide · 5 mg tablet
- Leocin Levofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Macromax Azithromycin · 250 mg capsule, 250 mg tablet, 500 mg tablet
- Mega HCQ Hydroxychloroquine · 200 mg tablet
- Mega Mether Artemether + Lumefantrine · 20 mg + 120 mg tablet
- Mega Mether 40/240 Artemether + Lumefantrine · 40 mg + 240 mg tablet
- Mega-C Ascorbic acid · 500 mg tablet
- Megadip Amlodipine · 10 mg tablet, 5 mg tablet
- Megafast Fexofenadine · 120 mg tablet, 180 mg tablet, 60 mg tablet
- Megalid Linezolid · 100 mg/5 mL suspension, 400 mg tablet, 600 mg tablet
- Megalor Loratadine · 10 mg tablet
- Megamycin Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Megapol Paracetamol · 500 mg tablet
- Megaprin Acetylsalicylic acid (Aspirin) · 300 mg tablet
- Megasar Losartan · 50 mg tablet
- Megatop Metoprolol Tartrate · 100 mg tablet
- Megazole Omeprazole · 20 mg capsule, 40 mg capsule
- Megazolin Dry Powder Cefazolin · 1 g injection, 250 mg injection
- Megtazidim Dry Powder Ceftazidime · 1 g injection, 250 mg injection
- Moxi Far Moxifloxacin · 400 mg tablet
- Olanzar - F Olanzapine, Olanzapine + Fluoxetine · 25 mg capsule, 25 mg + 12 mg capsule
- Olanzar - F 12/25mg Olanzapine + Fluoxetine · 25 mg + 12 mg capsule
- Olanzar - F 3 Olanzapine + Fluoxetine · 3 mg + 25 mg capsule
- Olanzar - F 3/25mg Olanzapine + Fluoxetine · 25 mg + 3 mg capsule
- Olanzar - F 6 Olanzapine + Fluoxetine · 6 mg + 25 mg capsule
- Olanzar - F 6/25mg Olanzapine + Fluoxetine · 25 mg + 6 mg capsule
- Olanzar-F Olanzapine + Fluoxetine · 12 mg + 25 mg capsule, 3 mg + 25 mg capsule, 6 mg + 25 mg capsule
- Ranzo Fluconazole · 150 mg capsule, 200 mg injection, 50 mg capsule
- Reliance Ranitidine · 150 mg tablet, 300 mg tablet
- Riteflox Ciprofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Seton Ondansetron · 4 mg tablet, 8 mg tablet
- Xemeg Dry Powder Cefotaxime · 1 g injection, 250 mg injection
Mega Pharmaceuticals: common questions
How many products does Mega Pharmaceuticals have in Pakistan?
Mega Pharmaceuticals limited has 127 registered medicine presentations in Pakistan, sold under 47 brands and covering 40 generic medicines.
What are the main brands of Mega Pharmaceuticals?
By number of registered strengths and packs, its largest brands are ATL (Atenolol), Megafast (Fexofenadine), Megapol (Paracetamol), Megazole (Omeprazole) and Leocin (Levofloxacin). This is not a sales ranking.
Which therapy areas does Mega Pharmaceuticals cover?
The most products are in Anti-infectives (47), Cardiovascular (24), CNS & mental health (15), Respiratory & allergy (12) and Gastrointestinal & hepatology (12).
Where can I see Mega Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.